Latency locus complements microRNA 155 deficiency in vivo

Journal of Virology

Volumn 87, Issue 21, 2013, Pages 11908-11911

  Sin, Sang Hoon ^a   Kim, Yong Baek ^b   Dittmer, Dirk P ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; MICRORNA 155;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CONTROLLED STUDY; GENE LOCUS; GERMINAL CENTER; HUMAN HERPESVIRUS 8; HUMORAL IMMUNE DEFICIENCY; IN VIVO STUDY; KNOCKOUT MOUSE; LYMPH NODE; MOUSE; NONHUMAN; ORTHOLOGY; PEYER PATCH; PRIORITY JOURNAL; SPLEEN; VIRUS LATENCY;

ANIMALS; GENETIC COMPLEMENTATION TEST; GERMINAL CENTER; HERPESVIRUS 8, HUMAN; HOST-PATHOGEN INTERACTIONS; IMMUNOGLOBULINS; LYMPH NODES; MICE; MICE, KNOCKOUT; MICRORNAS; PEYER'S PATCHES; RNA, VIRAL; SPLEEN;

EID: 84886930408     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01620-13     Document Type: Article

References (32)

1. Gottwein E, Corcoran DL, Mukherjee N, Skalsky RL, Hafner M, Nusbaum JD, Shamulailatpam P, Love CL, Dave SS, Tuschl T, Ohler U, Cullen BR. 2011. Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. Cell Host Microbe 10:515-526.
2. Haecker I, Gay LA, Yang Y, Hu J, Morse AM, McIntyre LM, Renne R. 2012. Ago HITS-CLIP expands understanding of Kaposi's sarcomaassociated herpesvirus miRNA function in primary effusion lymphomas. PLoS Pathog. 8:e1002884. doi:10.1371/journal.ppat.1002884.
3. Dittmer D, LagunoffM, Renne R, Staskus K, Haase A, Ganem D. 1998. A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus. J. Virol. 72:8309-8315.
4. Fakhari FD, Dittmer DP. 2002. Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR. J. Virol. 76:6213-6223.
5. Ohara AJ, Vahrson W, Dittmer DP. 2008. Gene alteration and precursor and mature microRNA transcription changes contribute to the miRNA signature of primary effusion lymphoma. Blood 111:2347-2353.
6. Ohara AJ, Wang L, Dezube BJ, Harrington WJ, Damania B, Dittmer DP. 2009. Tumor suppressor microRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma. Blood 113:5938-5941.
7. Sin S-H, Dittmer DP. 2013. Viral latency locus augments B-cell response in vivo to induce chronic marginal zone enlargement, plasma cell hyperplasia, and lymphoma. Blood 121:2952-2963.
8. Gottwein E, Mukherjee N, Sachse C, Frenzel C, Majoros WH, Chi J-TA, Braich R, Manoharan M, Soutschek J, Ohler U, Cullen BR. 2007. A viral microRNA functions as an orthologue of cellular miR-155. Nature 450: 1096-1099.
9. Skalsky RL, Samols MA, Plaisance KB, Boss IW, Riva A, Lopez MC, Baker HV, Renne R. 2007. Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J. Virol. 81:12836-12845.
10. Eis PS, Tam W, Sun L, Chadburn A, Li Z, Gomez MF, Lund E, Dahlberg JE. 2005. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. U. S. A. 102:3627-3632.
11. Tam W. 2001. Identification and characterization of human BIC, a gene on chromosome 21 that encodes a noncoding RNA. Gene 274:157-167.
12. Metzler M, Wilda M, Busch K, Viehmann S, Borkhardt A. 2004. High expression of precursor microRNA-155/BICRNAin children with Burkitt lymphoma. Genes Chromosomes Cancer 39:167-169.
13. van den Berg A, Kroesen B-J, Kooistra K, de Jong D, Briggs J, Blokzijl T, Jacobs S, Kluiver J, Diepstra A, Maggio E, Poppema S. 2003. High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma. Genes Chromosomes Cancer 37:20-28.
14. Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S, Heerema N, Croce CM. 2006. Pre-B cell proliferation and lymphoblastic leukemia/highgrade lymphoma in E-miR155 transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 103:7024-7029.
15. Boss IW, Nadeau PE, Abbott JR, Yang Y, Mergia A, Renne R. 2011. A Kaposi's sarcoma-associated herpesvirus-encoded ortholog of microRNA miR-155 induces human splenic B-cell expansion in NOD/LtSz-scid IL2Rnull mice. J. Virol. 85:9877-9886.
16. Dahlke C, Maul K, Christalla T, Walz N, Schult P, Stocking C, GrundhoffA. 2012. A microRNA encoded by Kaposi sarcoma-associated herpesvirus promotes B-cell expansion in vivo. PLoS One 7:e49435. doi:10.1371/journal.pone.0049435.
17. Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR, van Dongen S, Grocock RJ, Das PP, Miska EA, Vetrie D, Okkenhaug K, Enright AJ, Dougan G, Turner M, Bradley A. 2007. Requirement of bic/microRNA-155 for normal immune function. Science 316:608-611.
18. Thai T-H, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, Murphy A, Frendewey D, Valenzuela D, Kutok JL, Schmidt-Supprian M, Rajewsky N, Yancopoulos G, Rao A, Rajewsky K. 2007. Regulation of the germinal center response by microRNA-155. Science 316:604-608.
19. Vigorito E, Perks KL, Abreu-Goodger C, Bunting S, Xiang Z, Kohlhaas S, Das PP, Miska EA, Rodriguez A, Bradley A, Smith KGC, Rada C, Enright AJ, Toellner K-M, MacLennan ICM, Turner M. 2007. microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 27:847-859.
20. Zhao Y, Xu H, Yao Y, Smith LP, Kgosana L, Green J, Petherbridge L, Baigent SJ, Nair V. 2011. Critical role of the virus-encoded MicroRNA-155 ortholog in the induction of Marek's disease lymphomas. PLoS Pathog. 7:e1001305. doi:10.1371/journal.ppat.1001305.
21. Zhao Y, Yao Y, Xu H, Lambeth L, Smith LP, Kgosana L, Wang X, Nair V. 2009. A functional microRNA-155 ortholog encoded by the oncogenic Marek's disease virus. J. Virol 83:489-492.
22. Gatto G, Rossi A, Rossi D, Kroening S, Bonatti S, Mallardo M. 2008. Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-B pathway. Nucleic Acids Res. 36:6608-6619.
23. Linnstaedt SD, Gottwein E, Skalsky RL, Luftig MA, Cullen BR. 2010. Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus. J. Virol. 84:11670-11678.
24. Lu F, Weidmer A, Liu C-G, Volinia S, Croce CM, Lieberman PM. 2008. Epstein-Barr virus-induced miR-155 attenuates NF-B signaling and stabilizes latent virus persistence. J. Virol. 82:10436-10443.
25. Yin Q, McBride J, Fewell C, Lacey M, Wang X, Lin Z, Cameron J, Flemington EK. 2008. MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways. J. Virol. 82:5295-5306.
26. Fakhari FD, Jeong JH, Kanan Y, Dittmer DP. 2006. The latencyassociated nuclear antigen of Kaposi sarcoma-associated herpesvirus induces B cell hyperplasia and lymphoma. J. Clin. Invest. 116:735-742.
27. Sato S, Steeber D, Tedder T. 1995. The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation. Proc. Natl. Acad. Sci. U. S. A. 92:11558-11562.
28. Sin S-H, Fakhari FD, Dittmer DP. 2010. The viral latency-associated nuclear antigen augments the B-cell response to antigen in vivo. J. Virol. 84:10653-10660.
29. Jeong JH, Hines-Boykin R, Ash JD, Dittmer DP. 2002. Tissue specificity of the Kaposi's sarcoma-associated herpesvirus latent nuclear antigen (LANA/orf73) promoter in transgenic mice. J. Virol. 76:11024-11032.
30. Dittmer D, Stoddart C, Renne R, Linquist-Stepps V, Moreno ME, Bare C, McCune JM, Ganem D. 1999. Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SCID-hu Thy/Liv mice. J. Exp. Med. 190:1857-1868.
31. Hassman LM, Ellison TJ, Kedes DH. 2011. KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation. J. Clin. Invest. 121:752-768.
32. Qin Z, Freitas E, Sullivan R, Mohan S, Bacelieri R, Branch D, Romano M, Kearney P, Oates J, Plaisance K, Renne R, Kaleeba J, Parsons C. 2010. Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress. PLoS Pathog. 6:e1000742. doi:10.1371/journal.ppat.1000742